• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肛周克罗恩病肛瘘管理的当前综述

Current review of the management of fistulising perianal Crohn's disease.

作者信息

Adegbola Samuel O, Sahnan Kapil, Twum-Barima Charlene, Iqbal Nusrat, Reza Lillian, Lung Phillip, Warusavitarne Janindra, Tozer Phil, Hart Ailsa

机构信息

St Mark's Hospital and Academic Institute, Harrow, UK.

Department of Surgery and Cancer, Imperial College London, London, UK.

出版信息

Frontline Gastroenterol. 2020 Aug 13;12(6):515-523. doi: 10.1136/flgastro-2020-101489. eCollection 2021.

DOI:10.1136/flgastro-2020-101489
PMID:34712470
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8515276/
Abstract

Perianal manifestations of Crohn's disease constitute a distinct disease phenotype commonly affecting patients and conferring an increased risk of disability and disease burden. Much research has gone into management of fistulising manifestations, with biological therapy changing the landscape of treatment. In this article, we discuss the up-to-date surgical and medical management of perianal fistulas, highlighting current consensus management guidelines and the evidence behind them, as well as future directions in management.

摘要

克罗恩病的肛周表现构成一种独特的疾病表型,常影响患者,并增加致残风险和疾病负担。针对瘘管形成表现的管理已开展了大量研究,生物疗法改变了治疗格局。在本文中,我们讨论肛周瘘管最新的手术和药物管理方法,重点介绍当前的共识管理指南及其背后的证据,以及管理的未来方向。

相似文献

1
Current review of the management of fistulising perianal Crohn's disease.肛周克罗恩病肛瘘管理的当前综述
Frontline Gastroenterol. 2020 Aug 13;12(6):515-523. doi: 10.1136/flgastro-2020-101489. eCollection 2021.
2
Pathogenesis of Perianal Fistulising Crohn's Disease: Current Knowledge, Gaps in Understanding, and Future Research Directions.肛周瘘管型克罗恩病的发病机制:现有知识、理解差距和未来研究方向。
J Crohns Colitis. 2023 Jun 16;17(6):1010-1022. doi: 10.1093/ecco-jcc/jjad008.
3
Results of the Fifth Scientific Workshop of the ECCO [II]: Clinical Aspects of Perianal Fistulising Crohn's Disease-the Unmet Needs.欧洲克罗恩病和结肠炎组织(ECCO)第五届科学研讨会[II]的成果:肛周瘘管型克罗恩病的临床现状——未满足的需求
J Crohns Colitis. 2016 Jul;10(7):758-65. doi: 10.1093/ecco-jcc/jjw039. Epub 2016 Jan 28.
4
Classifying perianal fistulising Crohn's disease: an expert consensus to guide decision-making in daily practice and clinical trials.肛周瘘管性克罗恩病的分类:指导日常实践和临床试验决策的专家共识
Lancet Gastroenterol Hepatol. 2022 Jun;7(6):576-584. doi: 10.1016/S2468-1253(22)00007-3. Epub 2022 Mar 21.
5
Systematic review: the combined surgical and medical treatment of fistulising perianal Crohn's disease.系统评价:肛瘘性肛周克罗恩病的联合手术和药物治疗。
Aliment Pharmacol Ther. 2014 Oct;40(7):741-9. doi: 10.1111/apt.12906. Epub 2014 Aug 13.
6
Modern management of perianal fistulas in Crohn's disease: future directions.克罗恩病肛周瘘管的现代管理:未来方向。
Gut. 2018 Jun;67(6):1181-1194. doi: 10.1136/gutjnl-2017-314918. Epub 2018 Jan 13.
7
Infliximab in the treatment of Crohn's disease: predictors of response in an Italian multicentric open study.英夫利昔单抗治疗克罗恩病:一项意大利多中心开放性研究中的反应预测因素
Dig Liver Dis. 2005 Aug;37(8):577-83. doi: 10.1016/j.dld.2005.01.019.
8
Outcomes of Perianal Fistulising Crohn's Disease Following Anti-TNFα Treatment Discontinuation.抗 TNF-α 治疗停药后肛旁瘘管型克罗恩病的结局。
Inflamm Bowel Dis. 2018 May 18;24(6):1107-1113. doi: 10.1093/ibd/izy008.
9
[Efficacy of tumor necrosis factor-alpha inhibitors in fistulising perianal Crohn's disease].肿瘤坏死因子-α抑制剂在肛周瘘管型克罗恩病中的疗效
Orv Hetil. 2013 Dec 8;154(49):1943-8. doi: 10.1556/OH.2013.29770.
10
Understanding the role of the primary care physician in the management of patients with Crohn's perianal fistulas.理解初级保健医生在克罗恩病肛周瘘患者管理中的作用。
Postgrad Med. 2024 Jan;136(1):67-77. doi: 10.1080/00325481.2023.2277146. Epub 2024 Mar 6.

引用本文的文献

1
Perianal fistulizing Crohn's disease: Mechanisms and treatment options focusing on cellular therapy.肛周瘘管性克罗恩病:聚焦细胞治疗的机制与治疗选择
World J Gastroenterol. 2025 Mar 7;31(9):100221. doi: 10.3748/wjg.v31.i9.100221.
2
Perianal disease in inflammatory bowel disease: Broadening treatment and surveillance strategies for anal cancer.炎症性肠病的肛周疾病:拓宽肛门癌的治疗和监测策略。
World J Gastroenterol. 2024 Jul 28;30(28):3373-3385. doi: 10.3748/wjg.v30.i28.3373.
3
State-of-the-art surgery for Crohn's disease: part III-perianal Crohn's disease.克罗恩病的先进手术治疗:第三部分——肛周克罗恩病
Langenbecks Arch Surg. 2023 Mar 30;408(1):132. doi: 10.1007/s00423-023-02856-x.
4
Perioperative optimization of Crohn's disease.克罗恩病的围手术期优化
Ann Gastroenterol Surg. 2022 Oct 13;7(1):10-26. doi: 10.1002/ags3.12621. eCollection 2023 Jan.
5
The Optimal Management of Fistulizing Crohn's Disease: Evidence beyond Randomized Clinical Trials.瘘管性克罗恩病的优化管理:随机临床试验之外的证据
J Clin Med. 2022 May 28;11(11):3045. doi: 10.3390/jcm11113045.
6
Burden of disease and adaptation to life in patients with Crohn's perianal fistula: a qualitative exploration.克罗恩病肛周 fistula 患者的疾病负担和生活适应:定性探索。
Health Qual Life Outcomes. 2020 Nov 20;18(1):370. doi: 10.1186/s12955-020-01622-7.

本文引用的文献

1
Development and initial psychometric validation of a patient-reported outcome measure for Crohn's perianal fistula: the Crohn's Anal Fistula Quality of Life (CAF-QoL) scale.开发并初步验证一种用于评估克罗恩病肛周瘘的患者报告结局测量工具:克罗恩病肛周瘘生活质量量表(CAF-QoL)。
Gut. 2021 Sep;70(9):1649-1656. doi: 10.1136/gutjnl-2019-320553. Epub 2020 Dec 3.
2
Treatment of Perianal Fistulas in Crohn's Disease, Seton Versus Anti-TNF Versus Surgical Closure Following Anti-TNF [PISA]: A Randomised Controlled Trial.克罗恩病肛周瘘管的治疗:经 Anti-TNF 治疗后行皮筋结扎术与 Anti-TNF 治疗和手术闭合的比较(PISA):一项随机对照试验。
J Crohns Colitis. 2020 Sep 7;14(8):1049-1056. doi: 10.1093/ecco-jcc/jjaa004.
3
ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment.ECCO 指南:克罗恩病治疗——手术治疗。
J Crohns Colitis. 2020 Feb 10;14(2):155-168. doi: 10.1093/ecco-jcc/jjz187.
4
ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment.欧洲克罗恩病治疗指南:药物治疗
J Crohns Colitis. 2020 Jan 1;14(1):4-22. doi: 10.1093/ecco-jcc/jjz180.
5
British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.英国胃肠病学会成人炎症性肠病管理共识指南。
Gut. 2019 Dec;68(Suppl 3):s1-s106. doi: 10.1136/gutjnl-2019-318484. Epub 2019 Sep 27.
6
Mesenchymal Stem Cells for Perianal Crohn's Disease.间充质干细胞治疗肛门克罗恩病。
Cells. 2019 Jul 23;8(7):764. doi: 10.3390/cells8070764.
7
Systematic review and meta-analysis of endorectal advancement flap and ligation of the intersphincteric fistula tract for cryptoglandular and Crohn's high perianal fistulas.经肛门内括约肌切开术和结扎肛隐窝瘘管治疗隐窝腺源性和克罗恩病高位肛周瘘的系统评价和荟萃分析。
BJS Open. 2019 Jan 21;3(3):231-241. doi: 10.1002/bjs5.50129. eCollection 2019 Jun.
8
Medical-surgical Combined Approach in Perianal Fistulizing Crohn's Disease (CD): Doing it Together.肛周瘘管型克罗恩病的联合治疗(MDT):一起行动
Curr Drug Targets. 2019;20(13):1373-1383. doi: 10.2174/1389450120666190520103454.
9
Darvadstrocel for the treatment of patients with perianal fistulas in Crohn's disease.达维多司他用于治疗克罗恩病肛周瘘管患者。
Drugs Today (Barc). 2019 Feb;55(2):95-105. doi: 10.1358/dot.2019.55.2.2914336.
10
Anti-TNF Therapy in Crohn's Disease.抗 TNF 治疗克罗恩病。
Int J Mol Sci. 2018 Jul 31;19(8):2244. doi: 10.3390/ijms19082244.